Recombinant Leucine Rich Repeat Kinase 2 (LRRK2) Homo sapiens (Human) Recombinant protein

AURA17; PARK8; RIPK7; ROCO2; Dardarin ; Parkinson Disease(Autosomal Dominant)8; Leucine-rich repeat serine/threonine-protein kinase 2

  • Product No.RPH716Hu01
  • Organism SpeciesHomo sapiens (Human)
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular Locationn/a
  • Predicted Molecular Mass31.0kDa
  • Accurate Molecular Massn/a(Analysis of differences refer to the manual)
  • Residues & TagsPhe1479~Pro1729 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Pointn/a
  • ApplicationsSDS-PAGE; WB; ELISA; IP.
  • DownloadInstruction Manual
  • UOM 10ug50ug 250ug 1mg 1g
  • FOB US$ 192US$ 480 US$ 1200 US$ 2880 US$ 72000
  • Recombinant Leucine Rich Repeat Kinase 2 (LRRK2) Package and Components
  • Recombinant Leucine Rich Repeat Kinase 2 (LRRK2) Package and Components
  • RPH716Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered



Reconstitute in PBS or others.


Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.


The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.